The shorter estimate (21 days) provides safety margin
The EMAs drug safety committee (PRAC) launched a review of medicines containing semaglutide a GLP-1 agonist and the active ingredient in Novo Nordisk's Ozempic, Wegovy and Rybelsus in January, following concerns that the drugs could lead to an increased risk of developing non-arteritic anterior ischemic optic neuropathy (NAION)
Your provider can help you transition safely or maintain results with supportive supplements, nutrition strategies, and ongoing care
If you consume more than three alcoholic drinks daily, you should consult a healthcare provider before using these medications
They tend to get better with time but some side effects can happen at any time, or may be likely after a dose increase
A vitamin D level guides whether to correct a deficiency, since low vitamin D is associated with higher dementia risk in observational and genetic studies while supplementation trials for cognition have been null, so correcting a low level is reasonable and pushing it above normal is not